Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Adult Grade III Lymphomatoid Granulomatosis: early-phase trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Adult Grade III Lymphomatoid Granulomatosis: 3 US clinical trials tracked, none currently recruiting.

Adult Grade III Lymphomatoid Granulomatosis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is City of Hope Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition adult-grade-iii-lymphomatoid-granulomatosis

OPEN 0 | RECR 0% | LATE 0 | EARLY 3 | RANK #5209 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Adult Grade III Lymphoma (th…0%
Open-enrollment share among volume-matched conditions near Adult Grade III Lymphomatoid Granulomatosis

Adult Grade III Lymphomatoid Granulomatosis has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Adult Grade III Lymphomatoid Granulomatosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Adult Grade III Lymphomatoid Granulomatosis is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 13

Phase Distribution

PhaseTrial count
Phase 1 3

Named interventions

Most-linked intervention names on Adult Grade III Lymphomatoid Granulomatosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

autologous hematopoietic stem cell transplantation Procedure
2 trials
laboratory biomarker analysis Other
2 trials
positron emission tomography Other
1 trials
2'-F-ara-deoxyuridine Drug
1 trials
busulfan Drug
1 trials
autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells Biological
1 trials
peripheral blood stem cell transplantation Procedure
1 trials
pharmacogenomic studies Other
1 trials

US sites by state

Facility locations filed on Adult Grade III Lymphomatoid Granulomatosis trials. A trial with sites in several states counts in each.

Ohio 1 trials
Michigan 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Adult Grade III Lymphomatoid Granulomatosis page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Adult Grade III Lymphomatoid Granulomatosis trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • City of Hope Medical Center sponsors the most Adult Grade III Lymphomatoid Granulomatosis trials on record, review their full trial history before evaluating a specific study. See City of Hope Medical Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Adult Grade III Lymphomatoid Granulomatosis condition card totals 3 registered trials; most-linked intervention autologous hematopoietic stem cell transplantation; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.